Search
Physicians and scientists from MSK will join oncology experts and members of the global cancer research community to present the latest advances in cancer during the 2022 ASCO Annual Meeting, June 3–7 in Chicago.
The Howard Hughes Medical Institute (HHMI) announced that Memorial Sloan Kettering Cancer Center's Gerstner Sloan Kettering Graduate School of Biomedical Sciences is one of 23 research institutions to receive a grant as part of HHMI's Med into Grad Initiative.
President Biden announced the appointment of seven distinguished clinicians and researchers to the National Cancer Advisory Board. Memorial Sloan Kettering Cancer Center’s Luis Alberto Diaz, Jr., MD, was among those appointed.
A small molecule discovered at MSK called PU-H71 blocks the growth of cancer cells and enables doctors to image tumors.
Researchers devised a novel method to ferry drugs to head and neck cancers using nanoparticles that naturally stick to a protein in tumor blood vessels.
The United States Preventive Services Task Force released updated draft recommendations on colorectal cancer screening which, among other things, call for screening for the general population to begin at age 45.
Recently developed targeted drugs used to treat lung cancer are only partially effective. Scientists now know why.
Memorial Sloan Kettering Cancer Center announces the appointments of medical oncologist Anas Younes, surgical pathologist David S. Kimstra, surgeon Julio Garcia-Aguilar, and radiologist Wolfgang Weber.
Researchers clarify how the immune system activates an inflammatory defense against pathogens.